Capecitabine induced hypertriglyceridaemia: An underreported and potentially severe side effect
Journal Title: Journal of Cancer Research & Therapy - Year 2014, Vol 2, Issue 5
Abstract
A 57 year-old-woman, with no previous history of dyslipedemia, developed severe hypertriglyceridemia while being treated with capecitabine for metastatic breast cancer. Capecitabine was not discontinued and serum triglyceride levels were normalized after 4 weeks of treatment with fenofibrate. Capecitabine induced hypertriglyceridemia, as a rare drug-related side effect, seems to be often overlooked by clinicians.
Authors and Affiliations
Tabchi S, Joseph K
Keywords
Related Articles
- EP ID EP547471
- DOI 10.14312/2052-4994.2014-11
- Views 87
- Downloads 0
An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed non-Hodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database
We report a rare case of anaplastic large cell ALK+ lymphoma (ALCL) with initial asymptomatic cardiac involvement. A 59-year-old male with infiltration of the right ventricular wall underwent standard combined chemothera...
Clinical and prognostic significance of plasma fibrinogen in lung cancer
Objectives: Hyperfibrinogenemia is a common problem associated with various carcinomas. The recent studies have shown that high plasma fibrinogen concentration is associated with invasion, growth and metastases of cancer...
Prophylactic bundle for radiation-induced oral mucositis in oral or oropharyngeal cancer patients
Objective: In order to prevent and treat radiation-induced adverse events, especially oral mucositis, in patients with oral or oropharyngeal cancer receiving radiotherapy or chemoradiotherapy, a prophylactic bundle, i.e....
Factors associated with first-line bevacizumab use in advanced non-squamous non-small cell lung cancer
Introduction: Bevacizumab was approved for treatment of advanced non-squamous, non-small cell lung cancer (NSCLC) in the US in late 2006. Information on its uptake and patient and tumor factors associated with its use is...
With increasing age at tumor diagnosis in familial cancer: Cancer is limited to fewer organs
Hereditary cancer that has monogenic inheritance affects every tenth patient, on average, who is diagnosed with cancer, and it has been suggested, based on twin studies, that approximately 30% of all cancer patients have...